Melinta Therapeutics reports that Jennifer Sanfilippo has been named interim chief executive officer and director. Prior to this appointment, Ms. Sanfilippo served as senior vice president and general counsel of Melinta.
“Jennifer is an ideal addition to Melinta’s board of directors and we are pleased we will continue to benefit from her extensive leadership skills, proven track record and hands-on experience in the antibiotics sector within her new roles,” said David Gill, chairman of Melinta. more